{"id":246036,"date":"2012-06-11T23:14:28","date_gmt":"2012-06-11T23:14:28","guid":{"rendered":"http:\/\/www.eugenesis.com\/accelpath-inc-announces-dr-keith-j-kaplan-m-d-continues-role-as-chairman-on-company%e2%80%99s-medical-advisory-board\/"},"modified":"2012-06-11T23:14:28","modified_gmt":"2012-06-11T23:14:28","slug":"accelpath-inc-announces-dr-keith-j-kaplan-m-d-continues-role-as-chairman-on-companys-medical-advisory-board","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/pathology\/accelpath-inc-announces-dr-keith-j-kaplan-m-d-continues-role-as-chairman-on-companys-medical-advisory-board.php","title":{"rendered":"AccelPath, Inc. Announces Dr. Keith J. Kaplan, M.D. Continues Role as Chairman on Company\u2019s Medical Advisory Board"},"content":{"rendered":"<p><p>    GAITHERSBURG, Md.--(BUSINESS WIRE)--  <\/p>\n<p>    AccelPath, Inc. (ACLP)    (AccelPath or the Company) announced today that Dr.    Keith J.    Kaplan, M.D. continues his role as Chairman and active    member of the Companys Medical Advisory Board.  <\/p>\n<p>    Keith J.    Kaplan, MD is a pathologist and Chief Information    Officer (CIO) of Carolinas Pathology Group (CPG),    Celligent Diagnostics and Diligent Billing and Management. As    CIO, Dr. Kaplan is responsible for all aspects    of informatics strategies, operations, and projects and    processes that encompass laboratory, healthcare and research    information systems for Carolinas Pathology Group. Prior to    joining CPG, Dr. Kaplan was a surgical pathologist at Mayo    Clinic, Rochester, Minnesota and also held the academic post of    associate professor of pathology of Mayo Medical School.  <\/p>\n<p>    Dr. Kaplan is a graduate of Michigan State University, a    graduate of Northwestern University Feinberg School of Medicine    and completed residency training in anatomic and clinical    pathology at Walter Reed Army Medical Center, Washington, DC.    While at Walter Reed, Dr. Kaplan was named Resident of the Year    and, in conjunction with the Armed Forces Institute of    Pathology, Dr. Kaplan founded and directed the Army    Telepathology Program. This Program connected 25 hospitals    internationally for consultation via telepathology. Dr. Kaplan    also served as the Medical Director and Consulting Pathologist    of Laboratory Services at Keller Army Hospital in West Point,    New York.  <\/p>\n<p>    Dr. Kaplan is board certified in anatomic and clinical    pathology. His subspecialty interests include gastrointestinal    and hepatic pathology, cytopathology and pathology informatics    as well as research interests in gastrointestinal and    hepatobiliary pathology, hyperspectral imaging, image analysis    and the use of Web 2.0 tools in pathology. He has authored over    60 peer-reviewed scientific articles, book chapters, editorials    and scientific abstracts and frequently lectures at both    national and international meetings on topics related to    pathology informatics.  <\/p>\n<p>    Dr. Kaplan currently serves as a member of the College of    American Pathologists, American Society of Clinical Pathology    and the American Society of Cytopathology as well as the    American Pathology Foundation. He is also an executive board    member of the Digital Pathology Association. Dr. Kaplan has    previously served as a member of the College of American    Pathologists Informatics Committee, Standards Committee, and    Instrumentation Resource Committee and as co-chair of the    American Telemedicine Association Telepathology Special    Interest Group.  <\/p>\n<p>    We are very pleased with our collaborative relationship with    Dr. Kaplan, stated Shekhar Wadekar, AccelPaths Chairman and    Chief Executive Officer. Dr. Kaplans expertise in the    technical and medical components of digital telepathology    (through his experiences at Walter Reed Army Medical Center \/    the Armed Forces Institute of Pathology, founding and directing    the Army Telepathology Program, and industry experience as a    practicing pathologist) provides us significant insights while    we enhance our proprietary digital telepathology solutions. He    will also be invaluable as we further apply those to existing    pathology laboratories and related service providers.  <\/p>\n<p>    About AccelPath  <\/p>\n<p>    AccelPath provides technology solutions that play a key role in    delivering information required for diagnosis of diseases and    other pathologic conditions with and through its associated    institutional pathologists. The medical institutions, with whom    the Company partners, prepare comprehensive diagnostic reports    of a patients condition and consult with referring physicians    to help determine the most appropriate treatment. Such    diagnostic reports enable the early detection of disease,    allowing referring physicians to make informed and timely    treatment decisions that improve their patients health in a    cost-effective manner. The Company seeks out referring    physicians and histology laboratories in need of high-quality    pathology interpretations and manages HIPAA-compliant digital    case delivery and reporting while developing comprehensive    solutions for managing medical information.  <\/p>\n<p>    AccelPath is currently focused on the $14 billion anatomic    pathology market in the US. The Companys business model builds    upon the expertise of experienced pathologists to provide    seamless, reliable and comprehensive pathology and special test    offerings to referring physicians using conventional and    digital technologies.The Company establishes longstanding    relationships with the referring physicians as a result of    focused delivery of its partners diagnostic services,    personalized responses and frequent consultations, and its    proprietary flexible information technology, or IT, solutions    that are customizable to the referring physicians or    laboratories as well as the pathologists needs. Such    diagnostic reports often enable the early detection of disease,    allowing referring physicians to make informed and timely    treatment decisions that improve their patients health in a    cost-effective manner. AccelPaths IT and communications    platform enables it to efficiently and securely deliver    diagnostic reports to referring physicians. In addition,    AccelPaths IT platform enables close tracking and monitoring    of medical statistics.  <\/p>\n<\/p>\n<p>More here:<br \/>\n<a target=\"_blank\" href=\"http:\/\/finance.yahoo.com\/news\/accelpath-inc-announces-dr-keith-123000256.html;_ylt=A2KJNF_Qe9ZPtxkAJmn_wgt.\" title=\"AccelPath, Inc. Announces Dr. Keith J. Kaplan, M.D. Continues Role as Chairman on Company\u2019s Medical Advisory Board\">AccelPath, Inc. Announces Dr. Keith J. Kaplan, M.D. Continues Role as Chairman on Company\u2019s Medical Advisory Board<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p> GAITHERSBURG, Md.--(BUSINESS WIRE)-- AccelPath, Inc.  <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/pathology\/accelpath-inc-announces-dr-keith-j-kaplan-m-d-continues-role-as-chairman-on-companys-medical-advisory-board.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":57,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[577487],"tags":[],"class_list":["post-246036","post","type-post","status-publish","format-standard","hentry","category-pathology"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/246036"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/57"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=246036"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/246036\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=246036"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=246036"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=246036"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}